Trial Profile
A observational trial to evaluate the efficacy of raltegravir once a daily in switching strategy in HIV-1 infected patients with suppressed viraemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 06 Dec 2015 New trial record